ABT vs MCO · P/E 25, rev $44.33B vs P/E 33, rev $4.26B
Abbott Laboratories (ABT) versus Moodys Corporation (MCO) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Moodys Corporation (MCO) is a financial data & stock exchanges company listed on NYSE.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported MCO revenue for 2026-06-30 was $4.26B. Net income was $1.54B. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
Not investment advice. Open the ABT and MCO stock pages for the full models.
Not investment advice.